# SBIR Topic 133: Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections

> **NIH NIH N43** · IMMPORT THERAPEUTICS, INC. · 2024 · $300,000

## Abstract

To support the development of diagnostics for Herpes Simplex 1 and 2.

## Key facts

- **NIH application ID:** 11203298
- **Project number:** 75N93024C00044-0-9999-1
- **Recipient organization:** IMMPORT THERAPEUTICS, INC.
- **Principal Investigator:** DAVID CAMERINI
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $300,000
- **Award type:** —
- **Project period:** 2024-09-10 → 2025-09-09

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11203298

## Citation

> US National Institutes of Health, RePORTER application 11203298, SBIR Topic 133: Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections (75N93024C00044-0-9999-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11203298. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*